Yes, patients with dermatomyositis have a significantly increased risk of acute myocardial infarction
Patients with dermatomyositis face approximately a 3-4 fold increased risk of acute MI compared to the general population, with the highest risk occurring within the first year after diagnosis. 1, 2, 3
Magnitude of Risk
The cardiovascular risk in dermatomyositis is substantial and well-documented:
- Acute MI risk: A Taiwanese population-based study demonstrated an adjusted hazard ratio of 3.37 (95% CI 1.67-6.80) for acute MI in dermatomyositis patients compared to matched controls 1
- Combined dermatomyositis/polymyositis data: Another large cohort showed an adjusted hazard ratio of 1.98 (95% CI 1.17-3.35) for acute coronary syndrome 2
- Time-dependent risk: The risk is particularly elevated in the first year post-diagnosis, with hazard ratios reaching 6.51 (95% CI 3.15-13.47) for MI in polymyositis patients, with similar trends in dermatomyositis 3
Pathophysiologic Mechanisms
The increased MI risk stems from multiple mechanisms beyond traditional atherosclerosis:
- Chronic systemic inflammation: Similar to rheumatoid arthritis and lupus, dermatomyositis creates a pro-inflammatory state that accelerates atherosclerosis and promotes endothelial dysfunction 4
- Small-vessel vasculopathy: Dermatomyositis can cause coronary small-vessel disease independent of large-vessel atherosclerosis 5
- Vasospastic angina: Impaired vascular tone regulation can lead to Prinzmetal's angina, contributing to acute coronary events 5
- Direct myocardial inflammation: Myocarditis can occur, though this represents a different mechanism than ischemic MI 6, 7
Clinical Implications for Risk Management
Cardiovascular screening should be performed at diagnosis and monitored regularly, particularly during the first year:
- Obtain baseline troponin to evaluate myocardial involvement (troponin I is preferred as it's cardiac-specific, unlike CK which can be elevated from skeletal muscle inflammation) 8, 6
- Perform ECG and echocardiography at diagnosis 9
- Monitor for arrhythmias and conduction abnormalities, as QTc prolongation and ventricular repolarization abnormalities are common 10
- Consider cardiac MRI if there's clinical suspicion of myocardial involvement, as it can detect subclinical inflammation 11
Risk Modification Strategy
Aggressive cardiovascular risk factor management is essential:
- Control traditional risk factors (hypertension, hyperlipidemia, diabetes) according to standard guidelines 12
- Optimize disease activity control with immunosuppression, as active inflammation drives cardiovascular risk 12
- Minimize corticosteroid exposure when possible, as prolonged high-dose steroids contribute to cardiovascular risk 12
- Encourage smoking cessation, healthy diet, and regular exercise 12
Critical Pitfalls to Avoid
- Don't attribute all chest pain to musculoskeletal causes: Dermatomyositis patients presenting with chest pain require full cardiac evaluation, as symptoms may represent acute coronary syndrome, vasospastic angina, or myocarditis 5
- Don't rely solely on CK for cardiac assessment: CK elevation reflects skeletal muscle inflammation; use cardiac-specific troponin I instead 8, 6
- Don't assume normal coronary angiography excludes cardiac ischemia: Small-vessel disease and vasospasm may not be visible on standard angiography and may require provocative testing 5
- Recognize the first year as highest risk: Intensify cardiovascular surveillance during this period 3
The evidence consistently demonstrates that dermatomyositis confers substantial cardiovascular risk that warrants proactive screening, aggressive risk factor modification, and heightened clinical vigilance for acute coronary events.